Stripping corneal surgery of complications


DSAEK will soon replace conventional PK surgery for the treatment of endothelial decompensation

Where did it all begin?

In those patients suffering from endothelial decompensation (both primarily, i.e., Fuchs dystrophy, and secondarily after cataract surgery) but with an otherwise healthy cornea, simple "substitution" of the diseased endothelium with donor cells would succeed in both treating the pathologic condition and eliminating most of the complications related to conventional PK surgery.

All was not forgotten

Posterior lamellar keratoplasty was forgotten for three decades, until in 1993 Ko presented a poster at the annual ARVO meeting in Fort Lauderdale, describing a new technique of PLK in a rabbit model: both removal of the posterior lamella from the recipient and implantation of the donor posterior graft were performed through a sclero-corneal tunnel without "touching" the anterior corneal surface. However, hand-dissection of the recipient cornea was difficult and the resulting surface, even in the best cases, was never of an optical quality compatible with 20/20 vision.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Marjorie Rah, OD, PhD, FAAO
Dr Richard Lindstrom, Chairman of Surface Ophthalmics and founder of Minnesota Eye Consultants, speaks about ASCRS
Josefina Botta, MD, MSc, at ASCRS 2024
© 2024 MJH Life Sciences

All rights reserved.